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Abstract
Objectives: The aim of this study was to explore the development of soft tissue expanders, their
different types and their potential applications prior to bone augmentation and implant
placement.
Material and Methods: A review of pertinent literature was performed using PubMed to
comprehend the dynamics of soft tissue expanders and determine the current position of their pre-
augmentation applications.
Results: There is promising, albeit preliminary information regarding the benefits of pre-
augmentation soft tissue expansion. Findings cannot be generalised due to relatively small sample
size.
Conclusions: Further clinical trials with larger sample sizes and long-term follow-up are needed
before soft tissue expanders can be confidently applied in everyday clinical practice.
Periodontal disease is one of the most com-
mon diseases of the oral cavity, and it is pre-
valent in about half of the American adults
(Eke et al. 2012). Left untreated periodontal
disease can progress and cause destruction of
the attachment apparatus and loss of the sup-
porting alveolar bone, eventually ending in
tooth loss. In fact, periodontal disease is
listed as the major cause of tooth loss in
adults (Jenkins et al. 1988). Yet, dental caries
also contributes to high incidence of edentu-
lism (Copeland et al. 2004).
If there is no early replacement of lost
teeth, bone resorption will start and pro-
gress, causing significant changes of both
the horizontal and vertical dimension of the
alveolar ridge (Liu & Kerns 2014). Most of
these alterations occur within the first
3 months after extraction; Schropp et al.
(2003) reported a loss of 50% of crestal
width within these early stages. Current lit-
erature confirms that tooth extraction with-
out replacement may result in a reduction
of 40% of bone height and 60% of bone
width within the course of 2–3 years after
tooth loss (Ashman 2000).
In cases of severe bone resorption, vertical
and/or horizontal bone augmentation proce-
dures are mandatory prior to placement of
implants to achieve adequate dimensions of
the alveolar ridge, which in turn is necessary
to accomplish successful outcomes of
implant therapy, especially in anterior max-
illa which is an area of high aesthetic prior-
ity.
Different techniques have been described
for bone grafting: bone block and/or guided
bone regeneration (GBR) are used for horizon-
tal bone augmentation, with a good predict-
ability and satisfactory final outcomes
(McAllister & Haghighat 2007). Vertical bone
augmentations are technique sensitive as
well but even more challenging. Several sur-
gical techniques can be applied, such as verti-
cal GBR, onlay grafting, inlay grafting and
distraction osteogenesis (Rocchietta et al.
2008; Esposito et al. 2009). Moreover, vertical
bone augmentations are associated with high
complication rates, mainly soft tissue dehi-
scences, which are the primary cause for bone
graft exposures (Lundgren et al. 2008). As a
negative consequence, such complication can
lead to eventual partial or complete loss of
the bone augmentation material. Wound
dehiscences with subsequent bone graft
exposure may occur in up to 20% of vertical
bone augmentations (Jensen & Terheyden
2009; Kaner & Friedmann 2011). Similarly,
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Proussaefs & Lozada (2005) reported about
25% of bone graft exposures in patients who
got vertical bone augmentation with autoge-
nous bone blocks. This complication rate
was even higher (50%) in a work published
by Roccuzzo et al. (2007). In general, high
incidence of bone graft exposures has been
documented in the literature (Verhoeven
et al. 1997; Chiapasco et al. 2004; Merli
et al. 2007). Due to the aforementioned high
complication rate, the use of short dental
implants was suggested as an alternative to
grafting procedures in atrophic areas (Esposi-
to et al. 2011). This might be an acceptable
option in the posterior area. However, in the
zone of aesthetic priority, severe bone resorp-
tions have to be compensated by augmenta-
tion procedures to achieve satisfactory
aesthetic results.
As high complication rate has been
observed with different vertical bone aug-
mentation techniques, it can be extrapolated
that such complications might not be associ-
ated with the applied augmentation tech-
nique per se, but rather with the execution
and precision of the surgical procedure,
mainly with management and manipulation
of the soft tissues.
To ensure a successful final outcome of
any surgical procedure, a tension-free (pas-
sive) primary closure of the soft tissues is
important to preserve the vascularisation of
the tissues (Cordaro et al. 2002) and to
reduce the risk for subsequent post-surgical
infections (Wang & Boyapati 2006a,b).
As soft tissues follow the underlying bony
contour (Sonick & Hwang 2007), severe alve-
olar bone resorption in either the maxilla or
the mandible is usually accompanied by a
limited amount of soft tissues, which impairs
a tension-free primary closure of the soft tis-
sues. This might be even more compromising
when large amount of bone-grafting materials
are to be used (e.g. bone block grafts) in verti-
cal and/or horizontal bone augmentation pro-
cedures.
As a consequence in an attempt to achieve
complete and tension-free primary soft tissue
closure over the grafted area, flap advance-
ment is usually performed by mobilising the
muco-periosteal flap by deep periosteal
releasing incisions. This approach has been
recommended following major bone-grafting
procedures to achieve the aforementioned
goals (Greenstein et al. 2009). Vertical releas-
ing incisions negatively affect the perfusion
of the muco-periosteal flap (Mormann &
Ciancio 1977; Jivraj & Chee 2006; Esposito
et al. 2007), and because preservation of suffi-
cient blood flow is essential for the nutrition
of the soft tissues, a decrease in flap vascu-
larisation increases the risk of soft tissue
dehiscence (Nakayama et al. 1982). More-
over, periosteal releasing incisions compro-
mise the integrity of the periosteum
overlying the bone graft, which results in
diminished blood supply to the bone graft
(Abrahamsson et al. 2010), less new bone for-
mation and poor bone remodelling activity
(Zhang et al. 2008). The periosteum is a fun-
damental source of osteoblasts and their pre-
cursor cells (Allen et al. 2004), and hence,
presence of vital periosteal progenitor cells
on the surface of bone grafts accelerates bone
healing (Xie et al. 2007).
Moreover, flap advancement may result in
a reduction of the vestibule and a coronal dis-
placement of the muco-gingival junction,
which may compromise the final aesthetic
result and impair cleansing around prostheses
on implants (Jung et al. 2014).
When extensive flap advancements are
required, even if flap passivity has been
achieved with releasing incisions, the risk for
wound dehiscences may increase with nega-
tive consequences for the underlying bone
graft (Lundgren et al. 2008; Burkhardt & Lang
2010). Moreover, incomplete soft tissue cov-
erage results in a limited contact with area
between bone and flap, which in turn is nec-
essary for re-vascularisation of the bone graft
(Moghadam 2009) and which is important in
the prevention of an accelerated resorption of
the bone (Zerbo et al. 2003). It has been doc-
umented that flap tensions result in wound
dehiscences, irrespective of flap thickness
(Burkhardt & Lang 2010). In a clinical study
on implant patients, wound dehiscences
occurred in 40–100% of sites exposed to high
flap tensions (Burkhardt & Lang 2010).
In general, flap mobilisation seems to
increase the risk for soft tissue dehiscences
and, as a consequence, to compromise the
survival of the underlying bone graft.
Attempts to minimise the risk of post-surgi-
cal soft tissue dehiscence have been made by
utilising extra-oral approaches in bone aug-
mentation. Placement of bone grafts through
extra-oral incision was encouraged to avoid
the risk of intra-oral incision breakdown (Bell
et al. 2002). This approach was also adopted
to expose the facial blood vessels for anasto-
moses with free fibula flaps (segment of bone
with vascularised pedicle), to compensate for
the poor vascularisation of soft tissues associ-
ated with atrophy (Rohner et al. 2002; De
Santis et al. 2004; Chiapasco et al. 2011).
However, these methods are invasive as they
involve patient hospitalisation and an
increase in morbidity rate.
Notably, a considerable amount of bone
graft volume resorbs during the post-opera-
tive healing phase and as a part of the remod-
elling process regardless of other factors
(Cordaro et al. 2002; McAllister & Haghighat
2007). A compromised mucosal vascularisa-
tion and lack of tissue integrity will acceler-
ate bone resorption, beyond the commonly
seen remodelling activity (Lundgren et al.
2008; Rothamel et al. 2009). Hence, to pre-
vent such unfavourable results, improvement
of the quantity and quality of soft tissues
overlying bone grafts must be taken into con-
sideration (Kaner & Friedmann 2011).
An increase in soft tissue volume overlying
bone is well documented in distraction osteo-
genesis, which induces an expansion of both
bone and covering soft tissues (Rocchietta
et al. 2008; Esposito et al. 2009). However,
bone distraction is a complex and technically
demanding procedure. It requires a special
device that must be applied properly to avoid
serious complications (Uckan et al. 2002).
Alternatively, less invasive methods to cre-
ate a surplus of soft tissues, and therefore
reduce the risk for mucosal dehiscences, have
been investigated: periosteal distraction
(Schmidt et al. 2002; Kessler et al. 2007;
Sencimen et al. 2007; Oda et al. 2009; Tudor
et al. 2010) and tissue engineered periosteum
(Sch€onmeyr et al. 2009; Warnke et al. 2009).
In spite of the promising results, these meth-
ods are still experimental and have been
tested only in animal experiments. Further
investigations are obligatory to validate the
eligibility for their clinical applications.
Soft tissue expansion
Soft tissue expanders have been introduced in
implant surgery, as pre-augmentation
devices, to avoid the complications associ-
ated with bone-grafting procedures (Kaner &
Friedmann 2011; Mertens et al. 2015). The
concept of soft tissue expansion is based on
the biological properties of various soft tis-
sues, such as skin or mucous membranes, to
react to applied mechanical forces by true tis-
sue growth (cell proliferation) (Neumann
1957). This phenomenon can be observed in
abdominal skin during pregnancy, obesity,
muscle growth or lip and neck expansion as
a part of African traditions (Johnson et al.
1993). Soft tissue expanders have the capabil-
ity to enlarge soft tissue volumes without
altering its thicknesses and to generate tis-
sues with appropriate colour match and tex-
ture similar to that of the original tissues
(Fang et al. 2013). One of the clinical indica-
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tions of such technique is the preoperative
expansion of the oral mucosa when large
bone augmentations are planned. An over-
amount of soft tissues might reduce the need
for periosteal incisions and guarantee a pas-
sive flap closure covering the bone graft. Fur-
ther, intra-oral applications of soft tissue
expanders include the repair of lip and/or pal-
ate clefts.
The use of soft tissue expanders became
popular in the field of plastic surgery since
1976 (Uijlenbroek et al., 2011). The applica-
tions are well established for many indica-
tions, ranging from correction of skin burn
after burn wounds, scars, alopecia, congenital
nevi to post-mastectomy breast re-construc-
tion (Berge et al. 2001; Ronert et al. 2004;
Obdeijn et al. 2009; Chummun et al. 2010).
Recently, the “concept” of soft tissue expan-
sion has been introduced in orthopaedics. In
a clinical report, the successful application of
an “external” soft tissue expander to achieve
skin closure in open fractures was described
(Formby et al. 2013).
History and types of soft tissue expanders
Soft tissue expanders were first developed by
Neumann in 1957; who applied a subcutane-
ous rubber balloon to expand skin tissues in
order to repair an ear defect. Nonetheless, it
was not until the early 1980s when the real
interest in soft tissue expanders re-surfaced,
particularly in breast reconstruction (Radovan
1982) and treatment of burns (Argenta et al.
1983). The expanders used in these early
stages were made of silicone rubber, with an
external valve penetrating the skin for man-
ual inflation by serial injections, as illus-
trated in Fig. 1.
The amount of soft tissue gain with con-
ventional expanders has been reported to be
dependent on the type of expanded tissues
and the shape of the expanders (Brobmann &
Huber 1985; van Rappard et al. 1988). It was
observed that tissue gain was more pro-
nounced with rectangular and crescentic
forms compared with round-based expanders
(Johnson et al. 1993).
Despite the positive results with conven-
tional expanders, they have several disadvan-
tages, such as repetitive inflations, which
may increase the treatment time up to sev-
eral months. The intermittent modality of
external inflations creates pressure peaks
with a reduction in the tissue vascularity
(Pietila 1990), which in turn may cause an
expander perforation through the soft tissues
(Wiese 1993). A lack of perfusion caused by
pressure peaks reduces the local oxygen par-
tial pressure of the soft tissues and therefore
increases the risk for expansion failures
(Berge et al. 2001). Additionally, serial injec-
tions increase the costs of treatment and
morbidity of the patients as well as the risks
for adverse effects by repeated punctures.
Despite these drawbacks, conventional soft
tissue expanders are still used in plastic sur-
gical procedures. Due to the above-mentioned
shortcomings, the use of conventional
expanders is limited in cranio-facial defects
(van Damme et al. 1992).
To overcome the disadvantages of conven-
tional soft tissue expanders, Austad & Rose
(1982) developed a self-inflating osmotic soft
tissue expander, without an external port and
no need for repetitive inflations. The new
type of expander was based on a semi-perme-
able silicone membrane which contained
hypertonic sodium chloride solution. The
osmotic gradient allowed a continuous
inflow of body fluids into the expander. As a
consequence, the expander volume increased
with concomitant soft tissue growth. As a
negative effect, leaks occurred from the shell
of the expander to the surrounding tissues
resulting in tissue necrosis. These complica-
tions made the device inappropriate for clini-
cal application.
To overcome this major drawback, Wiese
(1993) developed a novel self-inflating osmot-
ically active soft tissue expander made of hy-
drogel.
It consists of both a polymer network
(cross-linked hydrogel of co-polymers based
on methyl methacrylate and N-vinyl-pyrroli-
done) (Wiese 1993; Wiese et al. 1999, 2001)
and a variable aqueous component (Refojo
1975). Since 1999, this hydrogel expander has
been designed and manufactured under the
name of Osmed (Ilmenau, Germany), which
is the first commercially available self-inflat-
able osmotic expander and has been FDA-
approved since 2001.
The biomaterials used are the same like in
contact lenses and offer a high biocompatibil-
ity without eliciting any toxic effects,
adverse immune reactions, infections or any
other systemic manifestations, and most
importantly, they do not provoke any local-
ised inflammatory reactions in the soft tis-
sues (Wiese et al. 2001). Incorporation of
methacrylate, in general, produces ionic hy-
drogels due to the presence of carboxyl moie-
ties, which results in a greater osmotic
potential and subsequent amplification of the
swelling capability in comparison with non-
ionic hydrogels (Wiese et al. 2001). Inclusion
of “methyl” methacrylate, specifically, in
osmotic hydrogel expanders results in an
increased swelling ratio (Wiese 1993; Wiese
et al. 1999, 2001) when compared to “hy-
droxyethyl” methacrylate (Downes et al.
1992).
The presence of cross-links renders the
polymer network insoluble in aqueous media
(Bell & Peppas 1996); thus, the expander has
the ability to swell and retain large volumes
produced by swelling and not dissolve in the
aqueous media. In an effort to test different
biomaterials, Varga et al. (2009) developed a
hydrogel osmotic soft tissue expander made
of either acrylamide (AAm), acrylic acid
(AAc) or N-isopropylacrylamide (NIPAAm).
Although NIPAAm hydrogels were proven to
be the most appropriate biologically and
mechanically for applications in plastic and
reconstructive surgeries, these expanders
were only tested in vivo and remain to be
validated in clinical trials.
As osmotic expanders abolish the need for
serial injections, they inflate continuously by
osmotic gradients without the need for addi-
tional interventions. A constant expansion
compared to an intermittent inflation results
in the formation of new cells, tissue growth
(van Rappard et al. 1988), and a greater
amount of final tissue gain (Wee et al. 1992;
Bennett & Hirt 1993; Bascom & Wax 2002).
Absence of an external filling port mini-
mises the bulkiness of the expansion device
(Swan et al. 2012), which facilitates the posi-
tioning of the expanders. With a starting vol-
ume of just 10% of the final volume,
osmotic expanders are initially smaller in
size than conventional expanders (Ronert
et al. 2004). As a consequence, osmotic
expanders require smaller incision for inser-
tion (Chummun et al. 2010), which reduces
surgical trauma (Figs 2 and 3). Miniaturised
osmotic expanders have been successfully
used in clinical ophthalmology (Schnittkow-
ski et al. 2003) and opened new indications
in paediatric surgery (Obdeijn et al. 2009).
There are two generations of Osmed hy-
drogel soft tissue expanders. The first genera-
Fig. 1. Conventional expander with an external port for
serial injections and manual inflation. Courtesy of:
Zeiter et al. (1998).
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tion lacks a silicone envelope surrounding
the surface of the hydrogel which results in
extremely rapid expansion, in the early stages
after insertion with consequent complica-
tions (Rees et al. 2008). Importantly, rapid
inflation does not result in an actual increase
in soft tissue volume because tissues need
time to adapt (Uijlenbroek et al., 2011). Early
studies showed that tissues might return to
their pre-expansion status in the case of rapid
expansion (Johnson et al. 1993).
To avoid such undesirable outcomes, a sec-
ond generation of osmotic hydrogel soft tis-
sue expanders, coated with silicone, have
been introduced in 2001 (Ronert et al. 2004).
Both generations are displayed in Fig. 4.
The perforations in the “impermeable” sili-
con shell allow the influx of surrounding flu-
ids. The number of perforations controls the
inflow rate which in turn limits the speed of
expansion (Kaner & Friedmann 2011). Com-
pared to the first generation, a less steep
swelling curve of the second-generation
expanders represents a continuous expander
growth with less pressure peaks (Ronert et al.
2004; Anwander et al. 2007). In other words,
inclusion of silicone coating adjusts the
expansion speed overall, which gives more
time for the newly formed tissues to adapt,
more time for wound healing and results in
greater amount of expanded tissue (Wee et al.
1992), and effective soft tissue generation
(Wiese 1993; Wiese et al. 2001). Comparisons
between osmotic expanders and conventional
expanders are summarised in Table 1.
In the following, we will refer to Osmed
expanders as they are the most widely
applied commercially available expansion
devices with sufficient evidence-based data.
Shapes, dimensions, expansion time and speed
of osmotic expanders
Osmotic soft tissue expanders are available in
different shapes with diverse “prior to inser-
tion/post-insertion” dimensions to match
their area of application. For example, round
shape is mainly used in breast reconstruction,
while rectangular shape is recommended for
defect coverage after excision of large skin
tumours and burns (Ronert et al. 2004). For
intra-oral uses, hemispheric and cylindrical
shapes are recommended by the manufacturer.
Fig. 3. Osmotic expander inserted through small inci-
sion. “Courtesy of: Rasperini, G. University of Milan,
Department of Biomedical, Surgical and Dental Sci-
ences, Foundation IRCCS Ca’ Granda Polyclinic, Milan,
Italy”.
Fig. 4. Rectangle osmotic hydrogel expander: from left
to right: un-swollen, without silicon shell, swollen.
“Courtesy of: Osmed GmbH (Ilmenau, Germany)”.
Table 1. Comparison between conventional and osmotic soft tissue expanders
Characteristic Osmotic expanders Conventional expanders
First development
of “concept”
Austad & Rose (1982) Neumann (1957)
Presence of an
external portal
No Yes
Size Small size, needing small
incisions for insertion
Bigger than osmotic expanders
Material Hydrogel cross-linked
co-polymers
Lack of silicone coating in
first generation
Presence of silicone coating
in second generation
Elastic silicone rubber
Mechanism of
expansion
Spontaneously by osmotic
forces from surrounding
fluids
Manual inflation by serial
injections through external portals,
by either the clinician, patients,
parents or guardians
Use in paediatric
patients
Encouraged Discouraged, due to injection-
related pain
Time for
expansion
Weeks or months Weeks or months
Mode of
expansion
Continuous
Rapid with first generation
Gradual and slow in second
generation
Intermittent
Development of
pressure peaks
Yes (first generation)
No (second generation)
Yes
Complications Minimal rate of
complications (mainly with
second generation)
Chances for relapse with
first generation
Infections, pain, ischaemia and
perforation
Amount of soft
tissue gain
Excellent amount due to
constant & gradual
pressure (second
generation)
Lack of actual tissue gain
with first generation
occasionally
Depends on the expanded host
soft tissue and the shape of the
expander
Cost Lower cost Higher cost because of the need of
serial injections
Area of current
applications
Craniofacial, intra-oral,
ophthalmologic
applications and plastic
surgery
Limited uses in plastic surgery
Fig. 2. Small incision is created for the insertion of
osmotic soft tissue expander. “Courtesy of: Rasperini,
G. University of Milan, Department of Biomedical, Sur-
gical and Dental Sciences, Foundation IRCCS Ca’ Gran-
da Polyclinic, Milan, Italy”.
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“Pre-insertion/post-insertion” dimensions are
accurately defined for each expander, which
simplifies surgical planning.
Once inserted, osmotic expanders have the
capability to expand ten times of their origi-
nal volume (Chummun et al. 2010), within
the time of approximately 6–8 weeks post-
insertion (Obdeijn et al. 2009). Results from
studies concluded that expanders can reach
six times their original volume, 2 weeks after
insertion (Abrahamsson et al. 2010).
This duration primarily depends on the
anatomical location, size of the defect (Ron-
ert et al. 2004) and the dimensions of the
expander (Mertens et al. 2015). Expanders
with bigger pre-insertion/post-insertion
dimensions require more time to achieve
their final size. Accordingly, the duration of
expansion may vary from 10 days to 8 weeks
(Ronert et al. 2004). Furthermore, the expan-
sion speed that dictates the time frame to
complete swelling depends on the shape of
the expander.
Round expanders for breast reconstructions
are left for approximately 4–6 months, as
they are replaced later on by permanent
implants.
As osmotic expanders have different shapes
and dimensions, each model apparently has
its own swelling curve. It is impossible to
modify the swelling characteristics of a cer-
tain type of expander after insertion (Uijlenb-
roek et al., 2011), and therefore, the
appropriate expander model should be chosen
prior to surgical placement.
Intra-oral applications of soft tissue
expanders
In cranio-facial surgery, the application of
expanders was first described by Argenta &
VanderKolk (1987). The use of soft tissue
expanders prior to bone augmentation of the
severely atrophic mandibular ridge has been
encouraged by early reports (Lew et al. 1988,
1991; Wittkampf 1989; Schwartz & Relle
1990; Bahat & Handelsman 1991; Zeiter
et al. 1998). However, conventional expand-
ers in the shape of silicone balloons were
applied in all these cases and they included
few patients without long-term follow-up, in
terms of stability or relapse of expanded soft
tissues and outcomes of hard tissue proce-
dures following expansion. Recently, osmotic
hydrogel soft tissue expanders of the second
generation have been investigated in intra-
oral applications.
Uijlenbroek et al. (2011) tested osmotic
soft tissue expanders in an animal study. To
validate the effectiveness and efficiency of
soft tissue expanders in various intra-oral
applications, the researchers placed the
expanders in the palatal mucosa of goats. As
the palatal mucosa is very firm in these ani-
mals, the researchers hypothesised that a
similar expansion would be successful in the
oral cavity of humans. Expanders were
implanted for 40 days, using either a “tun-
nel” approach or a “flap” approach. After
swelling, the expanders had created a surplus
of soft tissues with an excellent shape and no
signs of inflammation. Histological analysis
revealed no signs of bone resorption, despite
the pressure exerted on bone, which is equal
to the amount of pressure needed to expand
the soft tissues. Regarding the expander
insertion techniques, no difference was
observed between the tunnel and the flap
approach. With the tunnel technique, fixa-
tion of the expander was more challenging
compared to the flap approach due to
restricted view and limited freedom of han-
dling the expander. Based on the manufac-
turer’s guidelines for intra-oral use of the
expanders, insertion is recommended with
the “tunnel” technique. This approach pre-
vents a complete flap reflection for expander
placement.
In an in vivo experiment, Abrahamsson
et al. (2009) placed sub-periosteal osmotic
soft tissue expanders in mandibles of rabbits.
In each rabbit, two sites were assigned: test
site in contact with the base of the expander,
and control site which was the flat end of
the expander, fixed by a mini screw and has
no expanding capacity. Two weeks post-
expansion, clinical inspection showed no
signs of soft tissue dehiscence or infections
and histological examination revealed perio-
steal expansion without any signs of inflam-
matory reactions or bone resorption. In fact,
new bone formation at the edges of the
expanded periosteum was evident, while
there were no signs of bone formation in the
control area.
In a following experiment, the authors
applied the same animal model and protocol
in order to evaluate the outcomes of post-
expansion bone augmentation by GBR (with
particulate onlay bone graft and covered
either by titanium mesh or bioresorbable
mesh) (Abrahamsson et al. 2010). Three
months post-augmentation, it was evident
that tissue expanders were able to create a
sub-periosteal space and new bone formation
was allowed underneath the mesh and at the
edges of the expanded periosteum. The effect
of soft tissue expansion on the outcomes of
GBR with two different grafting materials
was evaluated in an another animal study
(Abrahamsson et al. 2011). In agreement with
previous findings, soft tissue expanders were
able to create a surplus of soft tissues includ-
ing periosteum, which facilitated mucosal
coverage of the bone graft without occurrence
of soft tissue dehiscences. New bone forma-
tion was found under the titanium mesh
regardless of the type of bone graft. Nonethe-
less, it must be noted that a lack of soft tis-
sue dehiscences or related complications in
this report may be attributed to the adopted
extra-oral surgical approach. The authors
chose such an approach as the access via the
oral cavity in rabbits was restricted (Abra-
hamsson et al. 2010).
There are just few clinical data available
which describe the mucosal expansion prior
to bone augmentation; two case series (Kaner
& Friedmann 2011; Mertens et al. 2015) and
one randomised controlled clinical trial
(Abrahamsson et al. 2012) could be found in
literature.
In a randomised controlled clinical trial,
Abrahamsson et al. (2012) applied sub-perio-
steal soft tissue expanders in ten patients
requiring bone augmentation prior to implant
placement. Two weeks post-insertion, the
expanders have been removed and GBR was
carried out with either a particulate onlay
graft protected by titanium mesh and a colla-
gen membrane (test group), or a cortical bone
block graft, harvested from the ramus, with-
out any previous soft tissue expansion (con-
trol group). The authors chose GBR as the
bone-grafting method in the test group for
two reasons: (i) predictable results have been
reported with regard to bone fill (Degidi et al.
2003), and (ii) promising results after mucosal
expansion have been described in previous
animal experiments (Abrahamsson et al.
2010, 2011).
In the test group, two patients showed
minor perforations of the soft tissues due to
expander placement close to incision line. In
these two cases, however, soft tissue expan-
sion was sufficient to completely cover the
bone graft with the mucosal flap, without
any complications. In the control group,
periosteal incisions were required to allow
flap advancement and achieve full coverage
of the bone grafts.
Changes in soft tissue profile of the
attached gingiva were evaluated at baseline
and 6 months after augmentation in both
groups and additionally at post-expansion in
the experimental group, by using an objective
3D metering device. This device is based on
digital light stripe projection which deflects
whenever the surface alters in topography.
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During the procedure, a clinical picture is
also taken. Deflection data are registered
through a sensor and stored in a computer
with appropriate software. Data are evaluated
and displayed as a colour-coded picture of the
topography (W€alivaara et al. 2007).
The software matched calibrated pictures
for each patient in both groups at different
time points. A line was drawn on the
matched pictures of at the level of the
attached gingiva and over the bone-aug-
mented area. The lines opened up in a dia-
gram which resulted in two or three curves
depending on the number of the measuring
occasions. These curves demonstrated soft
tissue profile at the specific area where the
lines were drawn. Alterations in soft tissue
profile overtime were determined by mea-
suring the height difference between the
curves. The mean soft tissue profile gain at
the attached gingiva level was 2.9  1.1 mm
when compared to baseline, while it
decreased to 2.3  2.1 mm at the time of
implant placement, when compared with
the starting point. The control group
showed a soft profile change of
1.5  1.4 mm at the time of fixture installa-
tion. Even if the test group showed
increased gingival dimensions after surger-
ies, the differences have not been not statis-
tically significant. The authors did not
measure the total volume change in soft tis-
sues, as they only wanted to determine
overall stability of created soft tissues by
evaluating soft tissue profile changes over-
time. Although soft tissue profile became
less prominent after healing of bone graft
when compared to pre-augmentation soft
tissue profile, this result was statistically
insignificant.
Six months post-operatively, the test group
showed a minimal resorption of bone graft in
the vertical dimension of just 27% and a ten-
dency for resorption in the horizontal aspect
(14%). Corresponding to earlier findings in
the literature (Chiapasco et al. 2006; McAllis-
ter & Haghighat 2007), vertical bone resorp-
tion was more pronounced than lateral one.
On the other hand, the control group
showed a statistically significant bone resorp-
tion in both the vertical (42%) and horizontal
(23.5%) dimension. Overall, bone resorption
in the experimental group was less pro-
nounced than that in the control group. How-
ever, the difference just reached statistical
significance when smokers have been
excluded from the calculation. Smokers have
been included in the study as they might be
candidates for such an approach in everyday
clinical practice.
The favourable outcome with expansion
could be attributed to the direct contact of
the bone graft with periosteal progenitor
cells. One might speculate that a reduced
bone graft resorption in the test group is
based on different augmentation modalities
in test and control group.
Despite the satisfactory results reported
with soft tissue expansion in animal and
human clinical trials, the authors recom-
mended further refinements of the soft tissue
expansion technique particularly in smoking
patients. Such refinements may mainly focus
on the risk reduction in complications such
as soft tissue perforation (Nystr€om et al.
2009; Lindfors et al. 2010).
Similarly, positive outcomes of pre-aug-
mentation soft tissue expansion were
reported by Kaner & Friedmann (2011) in a
case series. In contrast to the previous study,
the osmotic expanders have been placed in
submucosal pouches. The rationale for the
altered location was to prevent replacement
of periosteum with collagen-rich connective
tissues lacking osteoblasts and precursor
cells, which can have negative effects on the
healing of subsequent bone graft. We will
elaborate more about this later in this
review.
Of twelve patients enrolled in the study,
two experienced soft tissue perforations by
the expanders and had to be retrieved prior to
final expansion. Perforation occurred due to
infection 4 weeks post-insertion in one
patient, while the choice of an oversized
expander was the cause in the other one; a
fact that emphasises the selection of an
appropriate size of the expander. Perforated
sites were allowed to heal for 6 weeks and
then retreated with smaller expanders.
After 60 days in situ, all the expanders
reached their final volume and vertical bone
augmentation was carried out either with
onlay grafting (autogenous bone block har-
vested from the ileum in three patients) or
GBR (ramus graft covered with Bio-Oss and a
collagen membrane, in nine patients). During
removal of the expander, a surrounding cap-
sule of soft tissue could be observed which
did not show signs of inflammatory infiltra-
tion upon histological analysis. The expanded
tissues showed good quality, and the space
created by the expanders allowed a tension-
free primary closure. Despite the occurrence
of a minor exposure of bone graft in one
patient following vertical augmentation in
the posterior maxilla, spontaneous healing
occurred following local debridement without
any further complications. In the present
study, pre-augmentation soft tissue expan-
sion decreased the incidence of post-operative
graft exposure to 4% in comparison with pre-
vious studies of vertical bone augmentation
without prior soft tissue expansion of 23%
(Verhoeven et al. 1997), 27.3% (Chiapasco
et al. 2004), 25% (Proussaefs & Lozada 2005),
22% and 25% (Merli et al. 2007), and 33.3%
and 50% (Roccuzzo et al. 2007). After 4–
6 months of bone graft healing and just
before implant placement, cone beam com-
puted tomography (CBCT) analysis was per-
formed and revealed a high vertical bone gain
of 7.5  2.4 mm, in comparison with find-
ings from a recent systematic review, in
which mean vertical bone gain was reported
to be 4.8 mm with various augmentation
methods (Jensen & Terheyden 2009). It must
be noted that the amount of bone resorption
was not measured in this case series. Bone
biopsies were histologically analysed with
micro-computed tomography (micro-CT),
revealing appropriate bone volume density
(BV/TV) with distinct trabecular structure.
Implants have been placed after bone aug-
mentation, with uneventful healing.
In an alternative case series, sub-periosteal
osmotic expanders were applied by tunnel
approach in eight patients with severe atro-
phy in the maxilla or mandible before bone
augmentation (Mertens et al. 2015). Quality
and quantity of newly created soft tissues
were evaluated together with post-operative
soft tissue-related complications such as per-
foration, infection, dehiscence, necrosis and
pain. Expansion time varied between 20, 40
and 90 days depending on the size of the
defect and dimensions of the expander. Upon
insertion, patients reported a slight pressure
in the area, but without any symptoms of
pain. The only soft tissue-related complica-
tion was mucosal perforation accompanied
with eventual pre-mature loss of the expan-
der. Such complication occurred in two
patients; one had a history of a previous
trauma in the area of implantation, and the
other had experienced a cleft surgery and did
not follow the post-surgical instructions of
abstaining of wearing the prosthesis. Both
patients showed signs of mucosal scars prior
to insertion of the expander. This suggests
that case selection for soft tissue expansion
is essential to avoid complications and that
presence of scars at the surgical site might
be a contraindication for soft tissue expan-
sion. This hypothesis could not be con-
firmed in previous animal studies (van
Damme et al. 1994, 1997), and soft tissue
expansion was independent of the presence
of scarred tissue. On the contrary, skin
expansion decreased the limiting effect of
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scar tissues on restriction of mid-facial
growth (Edington et al. 1998), implying the
option of expanding compromised soft tis-
sues. Although the presence of scars might
not be an “absolute” contraindication for
expansion, it must be taken into consider-
ation that compromised soft tissues usually
have a lower expanding capacity compared
to normal ones (Fang et al. 2013).
In contrast to the previously mentioned
case series (Kaner & Friedmann 2011), re-
treatment with soft tissue expanders was not
carried out. All other patients experienced
uneventful healing free from any complica-
tions. Final expansion of the vestibular
mucosa was achieved, and all the expanders
reached their final size, limiting the amount
of gain of keratinized mucosa. It has to be
mentioned that the quality of the expanded
tissues was lining and not masticatory
mucosa. The authors explained that this
might be related to the applied expansion
technique, as all the expanders were placed
in the vestibule and thus were only sur-
rounded by alveolar mucosa.
After removal of the expanders, two recipi-
ent sites showed sign of resorption of the
underlying bone. This observation did not
have any adverse consequences, and the cor-
responding areas have been successfully aug-
mented later on.
Vertical and/or horizontal bone augmenta-
tions were performed with either autogenous
or synthetic block grafts. No periosteal
releasing incisions were needed to achieve
primary soft tissue closure over the bone
graft, except in the two patients who experi-
enced soft tissue perforation and pre-mature
removal of the expanders. Post-operative
healing of the grafts was uneventful. At the
time of implant placement, all bone grafts
were successfully healed and soft tissue
quantity was sufficient to passively close the
mucosal flaps. With the current expansion
techniques, careful evaluation of the amount
of keratinised and non-keratinised soft tis-
sues is required in order to accordingly plan
soft tissue expansion prior to bone or implant
surgery. It has been reported that a lack of
attached gingiva and presence of mobile soft
tissues might impair the fixation of the
expander (Park et al. 2013). On final clinical
follow-up, no complications were reported
and none of the placed implants were lost.
To summarise: Based on these three clini-
cal studies, it can be concluded that soft tis-
sue expansion prior to bone augmentation
may reduce the risk of mucosal dehiscence
with subsequent bone graft exposure. Addi-
tional randomised controlled clinical trials,
with an adequate sample size and long-term
follow-up, are needed to confirm these find-
ings. Summary of these clinical studies are
found in Table 2.
In two published case reports by Park et al.
(2013), sub-periosteal hydrogel osmotic
expanders were used prior to vertical bone
augmentation in severely resorbed mandibu-
lar ridges. They were left in situ for either 3
or 6 weeks. At the time of bone grafting, ten-
sion-free and complete closure of the aug-
mented bone with overlying soft tissues was
achieved. After healing, the grafted bone was
hard and intact clinically, and implants could
be placed without any complications. Similar
positive outcomes were documented with
pre-augmentation soft tissue expansion, in a
patient with significant bone resorption in
the posterior area of the mandible (von See
et al. 2010a).
Another indication where soft tissue
expanders have been applied is the repair of
lip and/or palate clefts. In vivo studies dem-
onstrated variable outcomes with the appli-
cations of soft tissue expanders. In a rabbit
cleft lip model, an overamount of soft tissue
was generated by expansion of the labial sur-
face area, resulting in reduced post-operative
lip pressure and improved mid-facial growth
(Edington et al. 1998). Conversely, in a cleft
lip and palate model in cats (van Damme
et al. 1997) even if soft tissue expansion of
the palatal muco-periosteum was feasible,
retardation of transversal growth was
reported as an iatrogenic side effect from
active expansion. Moreover, in a previous
cat model by the same researchers, active
expansion resulted in palatal bone resorption
(van Damme et al. 1994).
In a clinical study, Kobus (2007) used hy-
drogel soft tissue expanders as an adjunctive
in two-stage repair of cleft palate in children
over the period of 15 months. The clinician
intended to limit their palatal scarring and
therefore preserve maxillary growth. Of the
nineteen children enrolled in the study,
seven ended up with fistulae despite the
adjunctive application of soft tissue expand-
ers. The high rate of fistulae was explained
by the lack of silicon coating around the sur-
face of osmotic expanders (first generation)
which resulted in a super-quick expansion
with concomitant wound dehiscences. Swan
et al. (2008) criticised the fast expansion
technique in children and stated that the
available soft tissue expanders tend to expand
equally in all directions (i.e. isotropic), which
is not feasible in a confined area like the
palate. They recommended that directionally
dependent expansion must be developed to
allow for swelling in transverse direction
only.
A novel anisotropic self-inflating hydrogel
tissue expander was recommended that can
improve future clinical applications of soft
tissue expansion in cleft palate defects, eyelid
and nasal tip reconstruction.
This novel expander, based on methyl
methacrylate and vinyl pyrrolidone designed
to display anisotropy, showed a capacity for
considerable expansion and a controlled mod-
ifiable expansion rate (Swan et al. 2011).
Anisotropy was induced through compression
of hydrogel copolymer at elevated tempera-
tures (annealing), and expansion rate was
controlled by incorporation of a semi-perme-
able silicone membrane, in vitro. Efficacy of
this novel expander was later tested in vivo,
by sub-periosteal implantation in hard palates
of pigs (Swan et al. 2012). Uncoated and sili-
cone-coated expanders were compared
6 weeks post-expansion. Similar to all pub-
lished findings in the literature, uncoated
devices resulted in rapid expansion causing
muco-periosteal ulceration, while coated
ones displayed a more controlled expansion.
Coated expanders showed a significant
increase in soft tissue volume without any
evidence of acute inflammation. Formation
of soft tissue capsule was present around
these expanders, and expander-mediated ero-
sion of palatal bone could be observed.
Despite the promising results, clinical
research is needed to investigate the out-
comes of anisotropic expansion in specific
intra-oral applications.
Technical guidelines for insertion of soft tissue
expanders in pre-augmentation applications
The placement of soft tissue expanders in
the oral mucosa is technique sensitive, and
caution must be taken especially in tunnel
techniques. Their use in a moist environ-
ment might influence the operation time,
as soft tissue expanders start to swell once
in contact with the fluids. Thus, placement
of soft tissue expanders requires high tech-
nical skills of the surgeon. Screw fixation is
mandatory to avoid migration when sub-
jected to chewing or expanding forces. To
facilitate screw fixation, osmotic expanders
are fabricated with a flat end on one side,
as shown in Fig. 5. This flat area has no
expanding capacity. However, care must be
taken that even if screw-fixed, the expander
can still migrate if placed close to the inci-
sion line or mucosal perforation may occur
as negative side effects (Manders et al.
1984; Radovan 1984; Wieslander 1991; Abra-
hamsson et al. 2012). Usually, expanders are
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removed after successful mucosal expansion
and immediately prior to bone augmenta-
tion.
Tissue expansion can be done repeatedly
in the same area (Kaner & Friedmann 2011),
and increasing forms of expanders can be
indicated in large defects (Mertens et al.
2015). These findings are confirmed by stud-
ies dealing with soft tissue expansion in plas-
tic surgery (Roposch et al. 1999; Huo et al.
2009; Liu et al. 2011).
Effect of expansile pressure and
location of the expander on the
underlying bone
During the soft tissue expansion process, the
underlying bone surface serves as a counter-
bearing area for the expansile stress exerted
by expanders (Stuehmer et al. 2009). These
pressures could evoke bone reactive changes,
such as bone resorption.
There are conflicting findings in the litera-
ture about the reciprocal effects between soft
tissue expanders and bone; while some studies
reported about bone resorption (Hemmer et al.
1987; Antonyshyn et al. 1988a; Fudem & Or-
gel 1988; Tominaga et al. 1993; van Damme
et al. 1994; El-Saadi & Nasr 2008; Mertens
et al. 2015) or decreased bone density (Stueh-
mer et al. 2009), others did not observe any
signs of bone loss (Uijlenbroek et al., 2011) or
even documented new bone formation (Abra-
hamsson et al. 2009, 2010, 2011).
Despite these contradictions, bone resorp-
tion and deformation have been well docu-
mented with conventional expanders, used
in children and adults (Hemmer et al. 1987;
Table 2. Summary of clinical studies on pre-augmentation soft tissue expansion
Author &
year
Type of
study & no.
of subjects Treatment groups Type of expander
Shape of expander
& final volume or
dimensions
Location of
expander
Time needed for
full expansion
Soft tissue
complications
during
expansion
Soft tissue
quality
post-expansion
Kaner &
Friedmann
(2011)
Case Series
(12)
Soft tissue
expansion
followed by bone
augmentation in
all patients
Second-generation
hydrogel osmotic
expanders
Hemisphere with
0.35 ml final
volume or
Round-ended
cylinders with
0.24, 0.7, 1.3 or
2.1 ml final
volume
Submucosal
(in maxilla or
mandible)
60 days Soft tissue
perforation in
two patients,
due to
infection or
oversized
expander
Excellent
quality with
enough
created space
Abrahamsson
et al. (2012)
RCT (20) Test Group (10):
expansion
followed by bone
augmentation
Control Group
(10): bone
Augmentation
only
Second-generation
hydrogel osmotic
expanders
Shape: N/A Final
Dimensions:
5.6 9 11 9 6 mm
Sub-periosteal
(in maxilla or
mandible)
14 days Soft tissue
perforation
and projection
of expander
through
incision line in
two patients
Surplus
amount of
soft tissue
Mertens
et al. (2015)
Case Series
(8)
Soft tissue
expansion
followed by bone
augmentation in
all patients
Second-generation
hydrogel osmotic
expanders
Hemisphere or
cylinder with
0.24, 0.35, 0.7,
1.3 and 2.1 ml
final volume
Sub-periosteal
(in maxilla or
mandible)
20 or 40 or
90 days
(depending on
the size of the
defect)
Soft tissue
perforation in
two patients
with previous
history of
trauma or cleft
surgery
Excellent soft
tissue quality
and quantity
but no increase
in keratinized
gingiva
RCT, randomised clinical trial; NA, not announced.
Fig. 5. Osmotic expander with a flat-end to facilitate
screw fixation and prevent migration of the expander.
Flat ends have no expansion capability. “Courtesy of:
Rasperini, G. University of Milan, Department of Bio-
medical, Surgical and Dental Sciences, Foundation IR-
CCS Ca’ Granda Polyclinic, Milan, Italy”.
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Fudem & Orgel 1988; Paletta et al. 1989;
Penoff 1990; Schmelzeisen et al. 1999).
Expansion-mediated bone deformity might
be a minor clinical finding (Sinow et al.
1991). Nevertheless, in some cases the bone
deformations are not completely resolved
after expander removal and deformities will
remain (von See et al. 2010b). The causative
underlying effect might be the pressure
peaks associated with conventional expand-
ers. It is well documented that osteoclastic
activity increases in areas subjected to
higher pressure (Tominaga et al. 1993), espe-
cially when a certain threshold level has
been exceeded (Sato et al. 1998).
Early studies suggested that decreased
bone thickness and erosion are usually
evident on the bone surface below the
expander (Johnson et al. 1993), while
increased bone thickness, volume and
bone deposition are apparent at the
periphery of the expanders most of the
time, as a part of hyper-compensation
mechanism (Johnson et al. 1993). Hyper-
compensation occurs in the form of
increased bone apposition and micro-circu-
lation (Svindland et al. 1995), following
hypo-perfusion of the underlying bone
when the periosteum is elevated (Kowalski
et al. 1996) for expander placement.
To decrease the risks for bone resorption,
applied forces must be distributed over a
large surface area, like it happens with sec-
ond-generation expanders. Nonetheless, bone
resorption can occur with osmotic expander
when placed sub-periosteally, even without
pressure peaks. Sub-periosteal placement of
hydrogel expanders may impair micro-circu-
lation of the bone (Rucker et al. 2005), which
in turn causes bone resorption (Hemmer
et al. 1987) due to limited nutrition via the
periosteum (Chanavaz 1995).
Bone resorption with sub-periosteal
expanders was confirmed in a rat model
(Stuehmer et al. 2009); a significant decrease
in bone density and thickness in the area
underneath the expander was observed
21 days post-expansion. This was attributed
to the position of the expander directly on
bone.
Similarly, Mertens et al. (2015) observed
bone resorption with sub-periosteal expanders
in two patients but without any negative
effects on the final outcomes. Interestingly,
although the authors attributed these findings
to pressure on bone, one of the patients had
been fitted with two expanders but showed
bone resorption under one expander only. The
authors did not interpret this finding.
Signs of bone
resorption
post-expansion
Bone-grafting
technique
Need for periosteal
releasing incisions/flap
advancement
Adverse outcomes
post-augmentation
Analysis &
investigation Further findings Other comments
No signs of
bone resorption
Vertical bone
augmentation with
either autogenous
block graft or GBR
Tension-free closure was
achieved in all patients
Very low incidence of
graft exposure (4%).
(i) Clinical
(ii) Radiological
(CBCT) (iii)
Histological (iv)
Micro-CT analysis of
bone core biopsy
(i) Mean vertical bone
gain highly increased
(7.5  2.4 mm)
(ii) Encapsulation of all
expanders on
retrieval without
any signs of
inflammatory
infiltrate on
histological analysis
(iii) Good bone volume
density on micro-CT
(0.1614  0.0582)
(i) The authors did not
measure amount of
bone resorption post-
augmentation.
(ii) Patients who had
perforations were
retreated again with
expanders after time
for healing was
allowed.
NA Test Group:
Horizontal and
vertical bone
augmentation with
GBR Control Group:
Horizontal and
Vertical
augmentation with
autogenous block
graft
Only in the control
group
Test Group: statistically
significant bone loss in
vertical dimension only
(27%) (P = 0.04)
Control Group:
statistically significant
bone loss vertically
(42%) and horizontally
(23.5%) (P = 0.01,
P = 0.024, respectively)
(i) Clinical (ii)
Objective 3D
metering device
(i) Test group showed
less vertical and
horizontal resorption
of the bone graft in
comparison with the
control group, and
this was statistically
significant with the
exclusion of smokers.
(vertical, P = 0.12,
horizontal, P = 0.049).
(ii) Soft tissue profile was
less prominent after
healing of bone
grafts, but this was
statistically
insignificant.
(i) Authors excluded
smokers from the final
analysis.
(ii) Authors attributed
better results in
control group either
to soft tissue
expansion or to
different grafting
techniques between
groups.
(iii) Authors did not
measure the final
gained soft tissue
volume.
Two recipient
sites showed
signs of bone
resorption,
due to pressure
from expansion,
without
further
consequences
Vertical and/or
horizontal
augmentation with
either autogenous
or synthetic block
grafts
Only in the two patients
who pre-maturely lost
the expanders
None. All grafts were
successful at the time of
dental implant
placement
Clinical (i) Encapsulation of all
expanders on retrieval
(ii) Expansion time
depended on the
defect size and
expander dimensions
(i) Patients reported slight
pressure when the
expanders were placed,
without pain.
(ii) Patients who had
perforation were not
retreated with
expanders. They were
only treated with bone
augmentation.
(iii) Expanders improved
quantity and quality of
soft tissues but did not
alter the type of the
original soft tissue
subjected to
expansion
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In contrast, Abrahamsson and co-workers
suggested that placing the expanders in a sub-
periosteal location induced slow expansion of
the periosteum which resulted in new bone
formation at the periphery of the expanders
(Abrahamsson et al. 2009, 2010, 2011) with-
out any signs of bone resorption underneath
these devices. They assumed that the slow
expansion of the periosteum activated osteo-
genic cells which enhanced bone formation.
In fact, different studies confirmed that lift-
ing the periosteum slowly can result in new
bone formation, as it has been described for
periosteal distraction (Schmidt et al. 2002;
Kessler et al. 2007; Sencimen et al. 2007). In
an attempt to prevent direct contact
between expanders and bone, Kaner & Fried-
mann (2011) implanted the expanders in
submucosal pouches, which resulted in posi-
tive outcomes, without any signs of bone
resorption.
Further findings from the literature suggest
that bone resorption is in fact related to the
“amount” of pressure forces exerted on the
bone surface when the expanders are placed
sub-periosteally in direct contact with bone
and not on their position per se. Permanent
pressure on bone surpassing a certain thresh-
old can result in bone necrosis (Carlsson
2004). The maximum force exerted by
expanders is reported to be 32.4 kPa (Wiese
1993), and it has been demonstrated that per-
sistent compressive pressure of a threshold
surpassing 6.86 kPa leads to significant bone
resorption due to reduced perfusion (Sato
et al. 1998) in rats. However, critical pressure
force is expected to be much higher in
humans (Mertens et al. 2015). This might
explain why resorption with sub-periosteal
osmotic expanders was reported in rats
(Stuehmer et al. 2009), but not in humans
(Abrahamsson et al. 2012). In a rabbit model,
there were no signs of bone resorption due to
exerted pressure on bone (Abrahamsson et al.
2009), which proposes that critical pressure
also differs between different animals.
Distribution of pressure over a large area
could minimise the probability of surpassing
a certain threshold and thus reduce the risks
for bone resorption. von See et al. (2010b)
used a calvarial rat model to investigate
whether simultaneous insertion of mechani-
cal devices along with the expanders could
result in a better distribution of the load on
bone and over a larger surface area. Four
groups were compared: expanders alone,
expander with underneath titanium plate,
expander with underneath titanium mesh
and control group. Twenty-one days post-
expansion, micro-CT images and histological
analysis revealed significant decrease in
hydroxyapatite density and marked lacunae
beneath the osmotic hydrogel expanders
when they were applied without underlying
titanium mesh or plate, while such decrease
in bone density was reduced when titanium
mesh was placed, and totally prevented with
titanium plate. Moreover, bone thickness
was decreased with expanders solely or
expanders implanted on titanium mesh, but
not with expanders placed on titanium
plates. A compensatory increase in bone
thickness at the peripheries could be
observed in all the test groups, but not in the
control group. Although titanium mesh and
titanium plate acted as pressure distributors,
titanium plate disseminated forces more
effectively because expanders directly placed
on bone or titanium mesh induced connec-
tive tissue lacunae in the bone underneath
the expander. As a consequence, morphologic
changes can only be prevented with the util-
isation of titanium plates, as bone resorption
cannot be avoided with titanium mesh
underneath the expander.
In conclusion, bone resorption has been
very well documented with conventional
expanders, but inconsistent with osmotic
expanders. With sub-periosteal expanders,
bone resorption has been reported in vivo in
rats, due to low pressure threshold in small
animals, while there were conflicting find-
ings in studies on humans. Further clinical
investigations are mandatory to determine
the pressure threshold of expanders in
humans, which, if surpassed, might cause
bone resorption. Evaluation of the bone sur-
face reaction to applied soft tissue expansion
is also needed to confirm the preliminary
findings from the present clinical studies.
Effect of connective tissue capsule
surrounding the expanders on bone
augmentation
Connective tissue capsule formation is a
common finding around the expanders when
they have been retrieved (Pasyk et al. 1984).
Data from the early literature suggest that
dense fibrous capsule can develop around the
tissue expanders and completely surround
them within few days after insertion (Austad
et al. 1982; Pasyk et al. 1982, 1988; Argenta
et al. 1985). On the other hand, the capsule
thickness rapidly thins out after expander
removal (Johnson et al. 1993). These findings
could not be confirmed by recent studies
which showed that soft tissue capsule does
not form unless the expander is left in loca-
tion for more than 2 weeks (Kaner & Fried-
mann 2011; Abrahamsson et al. 2012;
Mertens et al. 2015).
In the previously mentioned study, Kaner
& Friedmann (2011) placed soft tissue
expanders in a submucosal pouch without
elevation of the periosteum, to avoid replace-
ment of periosteum with fibrous connective
tissue. Soft tissue capsule may negatively
affect the healing of bone following augmen-
tation. Periosteum is a fundamental source
for osteoblasts and their precursor cells
(Allen et al. 2004).
Encapsulation of sub-periosteal expanders
can be avoided if they are left in situ for just
a short period of time; Abrahamsson et al.
(2012) removed sub-periosteal expanders
14 days post-insertion without any signs of
fibrous tissue encapsulation. This had posi-
tive effects on bone augmentation, docu-
mented in their rabbit models; there was an
evident direct contact between progenitor
cells populating the periosteum and the bone
graft in histological analysis (Abrahamsson
et al. 2010, 2011). Although encapsulation
was not reported, it was evident in earlier
rabbit models, in which all expanders were
covered by collagen-rich capsule within
2 weeks after insertion (Abrahamsson et al.
2009).
Encapsulation was evident when sub-perio-
steal expanders were retrieved after 20, 40 or
90 days (Mertens et al. 2015). Fibrous tissue
encapsulation seems to be inevitable if the
expanders are left in place for a long time,
regardless of their location; it was obvious
with submucosal soft tissue expanders that
were left in location for 60 days (Kaner &
Friedmann 2011).
Based on these findings, it was suggested
that caution must be taken not to leave sub-
periosteal expanders for a long time; other-
wise, fibrous connective tissue replacement
of the periosteum should be expected (Abra-
hamsson et al. 2012).
Mertens et al. (2015) did not report any
negative outcomes following bone augmenta-
tion and implant placement, despite the
development of a soft tissue capsule around
the sub-periosteal expanders. A recent in vivo
study revealed that, although sub-periosteal
implantation of expanders resulted in com-
plete ischaemia of the periosteum and was
replaced by fibrous connective tissue within
14 days, these tissues had significantly
higher density of micro-vessels than a
healthy periosteum which did not have any
negative effects on vascularisation to the
bone (von See et al. 2010c). Such findings
might justify bone augmentation immedi-
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ately following the completion of soft tissue
expansion, even if there is complete replace-
ment of the periosteum with a fibrous tissue
capsule. Earlier studies included recommen-
dations for a delayed bone-grafting procedure
after soft tissue expansion (LaTrenta et al.
1988).
More clinical trials are needed to evaluate
the effect of connective tissue capsule forma-
tion on subsequent bone augmentation.
Effect of soft tissue expanders on
micro-circulation and soft tissue
vascularisation
Integrity of vascularisation is important to
ensure successful outcomes of the surgical
procedures. Different studies have been con-
ducted to evaluate the effect of soft tissue
expansion on vascularisation of the soft tis-
sues.
In an in vivo study on beagle dogs, Kaner
et al. (2014) evaluated the effect of submuco-
sal soft tissue expansion on mucosal micro-
circulation. Following surgical interventions,
there is a hyperaemic response of the perio-
steal and supra-periosteal blood vessels dur-
ing the first 3 days post-operatively (Caffesse
et al. 1981; Nobuto et al. 2005). Although
micro-circulation was reduced after local
anaesthesia, there was a reduction in post-
operative hyperaemic response during the
first 3 days post-surgery. This fact may be
attributed to minimal surgical trauma as
preparation of a submucosal pouch only
requires a minimally invasive surgical
approach without any need for elevation of
the periosteum. The study conductors con-
cluded that microcirculation is minimally
and momentarily disturbed by insertion of
expanders, which explains the positive out-
comes with submucosal expanders, in previ-
ous investigations (Kaner & Friedmann
2011).
In another animal model on beagle dogs,
the authors evaluated micro-circulation in
vertical bone augmentation following soft tis-
sue expansion (Kaner et al. 2015). Augmenta-
tion surgery impaired micro-circulation in
control group, but did not cause further
decrease in sites treated with expanders,
beyond that of local anaesthesia. Two weeks
post-augmentation, micro-circulation was
significantly lower for the control group,
compared to test group, and although no
signs of wound dehiscence were reported in
the test group (with expanders), eight wound
dehiscences were evident in the control
group (without expanders). Based on that
study, it seemed that soft tissue expansion
may lower the impairment of micro-circula-
tion caused by vertical ridge augmentation
and reduce the incidence of soft tissue dehi-
scences.
Even if expander losses were low in a case
series of patients, 30% of the expanders were
lost in this animal study. The authors attrib-
uted this finding to possible continuous
uncontrolled mastication on the surgical
sites, despite the proper surgical execution.
In another in vivo study on rats, von See
et al. (2010d) reported a higher density of
micro-vessels in the soft tissue surrounding
the augmentation material when pre-aug-
mentation soft tissue expansion was utilised,
in comparison with grafted area without a
prior soft tissue expansion. This was in agree-
ment with early studies which confirmed an
increase in the vascularity of the expanded
tissues. Histological findings revealed that
rapid angiogenesis is evident with increased
number of blood vessels at the junction
between connective tissue capsule and host
tissues, which contributes to an actual
increase in the vascularity of the expanded
soft tissues (Johnson et al. 1993). Subsequent
bone augmentation did not have any influ-
ence on functional micro-vessel density
caused by soft tissue expansion. Complete
osseo-integration of the bone graft was possi-
ble when the mucosal perfusion around the
augmentation area was not compromised
(von See et al. 2010d). High vessel density of
soft tissues seems to play a role in blood sup-
ply to the underlying bone (Chanavaz 1995).
Absence of periosteal perfusion was
observed in bone augmentation without pre-
vious soft tissue expansion caused by surgi-
cal dissection of the periosteum (Kowalski
et al. 1996). Additionally, the periosteum
will be subjected to tensile forces during
the surgical procedure which further
impairs the patency of the vessels (von See
et al. 2010d).
It can be concluded that, regardless of the
location of the expanders, tissue expansion
tends to increase vascularisation of the soft tis-
sues and also reduces adverse effects on micro-
circulation following bone augmentation.
Summary of relevant in vivo studies are
presented in Table 3.
Long-term outcomes of
applications of osmotic hydrogel
soft tissue expanders
As the application of soft tissue expanders for
intraoral mucosal expansion is relatively
new, no long-term results are available. Clin-
ical guidelines may be extrapolated from
studies that describe the use of osmotic
expanders in plastic surgery.
Chummun et al. (2010) published their
5-year experience with soft tissue expanders
through retrospective data collection. Ten
patients have been treated with soft tissue
expanders for either alopecia, scars or burn
contracture. Six patients had an uneventful
post-operative healing, and the required
amount of soft tissues was obtained without
any complications. The other four patients
developed different degrees of wound infec-
tion. Based on the high complication rate,
the authors suggested that identifying a suit-
able anatomical location and proper case
selection seems to be mandatory in order to
avoid any complications. Similarly, Obdeijn
et al. (2009) reported a high complication rate
in a 3-year clinical experience. From nine
patients treated, complications of infections,
ischaemia of the skin and expander migration
were reported in five patients. In two cases,
complications were attributed to previous
irradiation in the area where the expander
was inserted. As a matter of fact, previous
irradiation and infected areas are contraindi-
cations for implantation of tissue expanders
(Ronert et al. 2004). However, if using soft
tissue expanders are indicated, radiation ther-
apy should only start after the completion of
the expansion phase (Ronert et al. 2004).
Obdeijn et al. (2009) expanded scalp skin in
five patients, and confirmed by previous data,
they found high complication rate when
expanders are applied in the head and neck
areas (Antonyshyn et al. 1988b). Nonetheless,
data from a 15-year retrospective study
revealed that a high complication rate with
head and neck soft tissue expansion could be
noticed, but the severity of complications
was of minor importance (Belghith et al.
2012).
The authors recommended that indications
for soft tissue expansion must be considered
carefully, not to change the advantages of tis-
sue expansion into a disadvantage by increas-
ing complications (Obdeijn et al. 2009).
A more positive experience with soft tissue
expanders was published by Ronert et al.
(2004) in which they used expanders in 58
patients for different extra-oral indications,
mainly in breast reconstructions, over the
period of 4 years. They reported a success
rate of 81.5% in expanders without a silicone
envelope, while it was up to 91% with sili-
cone-coated expanders. The authors consid-
ered the final outcome as successful when
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there was adequate soft tissue gain with good
final aesthetic appearance.
Regarding soft tissue expansion in paediat-
ric patients, high complication rates, most
commonly infection, have been reported (Pi-
sarski et al. 1998; De Agustin et al. 1993;
Iconomou et al. 1993; Gibstein et al. 1997;
Neale et al. 1998; Hurvitz et al. 2005). Com-
plication rates in children undergoing soft tis-
sue expansion have been reported to be high,
ranging between 20% and 40% (Friedman
et al. 1996).
According to published data, the source of
infections could be distant from the location of
the expander (Mason et al. 1999), such as
endogenous sources like pharyngitis or otitis
media, which suggest the relocation of the aeti-
ological bacteria from the infection site to the
expander through dissemination by haematog-
enous or lymphatic pathways. Despite using
conventional soft tissue expanders which
already increase the risk of infections, Adler
et al. (2009) concluded that infection did not
hamper further expansion or successful recon-
struction, in concordance with other reports
(Radovan 1984; Antonyshyn et al. 1988a).
Although the role of antibiotics to prevent
bacterial seeding on the expander from remote
infected sites still needs to be evaluated, it
might be preferable to prescribe antibiotics in
individuals with high risk of developing infec-
tions. This might be valid as well for the
application of intra-oral soft tissue expanders.
Additionally, we suggest that expander place-
ment adjacent to teeth must be prepared by a
careful periodontal screening and treatment
in order to avoid wound infections.
To avoid expander infection, Wacke et al.
(2011) studied hydrogel osmotic expanders as
a drug delivery system for antibiotics, in vitro.
Expanders were incubated with either tobra-
mycin or ofloxacin, in a setting that simu-
lates the orbit of a newborn. Results showed
that antibiotic release from the expander to
the surrounding environment was sufficient
and in effective concentrations which can be
useful in preventing post-implantation infec-
tions in future clinical applications, and also
eliminating the adverse effects associated
with the administration of systemic antibiot-
ics. Such expanders should also be tested for
intra-oral applications, as they might
decrease infection complication rates.
For intra-oral applications, soft tissue
expansion should be avoided in irradiated and
actively infected sites.
Recommendation and future
directions
Applications of soft tissue expanders prior to
bone augmentation and placement of endos-
seous implants are still in a preliminary
phase. Despite the initial promising results
from the presented clinical studies, further
clinical investigations are mandatory to work
out clinical guidelines and protocols to define
indications and contraindications for pre-aug-
mentation applications. The effect of soft tis-
sue expansion to the bone needs to be
determined, as well as the effect of the loca-
tion of the expander and the amount of
applied pressure.
The relationship between soft tissue expan-
sion and tissue biotype (thick vs. thin) has
not been addressed yet in the literature.
Thus, the effect of tissue biotype on the
final outcomes of pre-augmentation soft
tissue expansion needs to be investigated.
Moreover, the relationship between the rate
of expansion and tissue biotype and the
determination of a suitable expander inser-
tion technique for each biotype should be
evaluated as well.
Conclusion
An ideal expander requires the following
characteristics, as described by Mazzoli et al.
(2004): (i) it should be easy to manipulate and
place especially in sites with small access,
(ii) it should expand gradually and controlla-
bly over a short period of time, yet tolerable
on long term, without inducing pressure
spikes resulting in complications, such as
infections and extrusion of expanders. These
requirements are met with the osmotic
expanders, mainly second generation. Based
on the results presented in this review, there
is promising, albeit preliminary information
regarding the benefits of pre-augmentation
soft tissue expansion. The previous findings
cannot be generalised due to relatively small
sample size. Further clinical trials with a lar-
ger sample sizes and long-term follow-up are
needed before implementing soft tissue
expanders into everyday clinical practice.
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